Emili Montserrat

Emili Montserrat

UNVERIFIED PROFILE

Are you Emili Montserrat?   Register this Author

Register author
Emili Montserrat

Emili Montserrat

Publications by authors named "Emili Montserrat"

Are you Emili Montserrat?   Register this Author

100Publications

3186Reads

18Profile Views

Predicting the outcome of patients with chronic lymphocytic leukemia: Progress and uncertainty.

Cancer 2019 Nov 5;125(21):3699-3705. Epub 2019 Aug 5.

Division of Experimental Medicine, Department of Medicine, Hematology Research Centre, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32353DOI Listing
November 2019

Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis.

Clin Lymphoma Myeloma Leuk 2019 Jul 23;19(7):423-430. Epub 2019 Mar 23.

Hospital Clinic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.03.014DOI Listing
July 2019

Novel pathway inhibitors for the treatment of chronic lymphocytic leukaemia.

Lancet Haematol 2019 Feb;6(2):e65-e66

Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026183022
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(18)30222-9DOI Listing
February 2019

Critical molecular pathways in CLL therapy.

Mol Med 2018 03 15;24(1). Epub 2018 Mar 15.

Department of Hematology, Institute of Hematology and Oncology, University of Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s10020-018-0001-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016889PMC
March 2018

Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia.

Blood Cancer J 2018 01 16;8(1):10. Epub 2018 Jan 16.

Department of Hematology, Institute of Hematology and Oncology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-017-0044-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802533PMC
January 2018

Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.

Am J Hematol 2017 Jun 24;92(6):E91-E93. Epub 2017 Mar 24.

Institute of Haematology and Oncology, Hospital Clínic University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24707DOI Listing
June 2017

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.

Am J Hematol 2017 Apr 13;92(4):375-380. Epub 2017 Feb 13.

Department of Hematology, Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24660DOI Listing
April 2017

CLL: when the target of treatment is disease-related symptoms.

Lancet Haematol 2017 Feb 12;4(2):e57-e58. Epub 2017 Jan 12.

Institute of Haematology and Oncology, Hospital Clínic University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(16)30186-7DOI Listing
February 2017

Maintenance therapy in chronic lymphocytic leukaemia.

Lancet Haematol 2016 09 1;3(9):e399-400. Epub 2016 Aug 1.

Department of Haematology, Institute of Haematology and Oncology, University of Barcelona, Hospital Clínic, 08036 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(16)30081-3DOI Listing
September 2016

Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S74-81

Department of Medicine V, University of Heidelberg, Heidelberg, Germany; European Society for Blood and Marrow Transplantation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.013DOI Listing
August 2016

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

Haematologica 2016 Mar;101(3):263-5

Division of Experimental Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele and IRCCS Instituto Scientifico San Raffaele, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.139246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815716PMC
March 2016

Present and future of personalized medicine in CLL.

Best Pract Res Clin Haematol 2016 03 12;29(1):100-110. Epub 2016 Aug 12.

Institute of Haematology and Oncology, Hospital Clínic University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.009DOI Listing
March 2016

CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.

Br J Haematol 2016 Jan 12;172(1):48-55. Epub 2015 Nov 12.

Department of Haematology, Institute of Haematology and Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13788
Publisher Site
http://dx.doi.org/10.1111/bjh.13788DOI Listing
January 2016

Primary CNS lymphoma: in search of the evidence.

Authors:
Emili Montserrat

Lancet Haematol 2015 Jun 3;2(6):e227-8. Epub 2015 Jun 3.

Institute of Hematology and Oncology, CLL and Lymphoma Program, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00091-5DOI Listing
June 2015

Hope for high-risk chronic lymphocytic leukemia relapsing after allogeneic stem-cell transplantation.

J Clin Oncol 2015 May 13;33(14):1527-9. Epub 2015 Apr 13.

University of Heidelberg, Heidelberg, Germany; and European Society for Blood and Marrow Transplantation, Lymphoma Working Party, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.3282DOI Listing
May 2015

Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?

Curr Hematol Malig Rep 2015 Mar;10(1):59-64

Department Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-014-0242-1DOI Listing
March 2015

New treatment options for chronic lymphocytic leukemia.

Expert Opin Pharmacother 2014 Apr 22;15(6):823-32. Epub 2014 Feb 22.

University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institute of Hematology and Oncology, Hospital Clínic, Department of Hematology , Villaroel 170, 08036 Barcelona , Spain +34 93 227 54 75 ; +34 93 227 98 11 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.891017DOI Listing
April 2014

Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.

Clin Lymphoma Myeloma Leuk 2014 Feb 12;14(1):73-9. Epub 2013 Oct 12.

Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.08.003DOI Listing
February 2014

B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.

Br J Haematol 2014 Feb 18;164(4):570-8. Epub 2013 Nov 18.

Department of Haematology, Institute of Haematology and Oncology, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12645DOI Listing
February 2014

MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.

Leuk Lymphoma 2013 Sep 29;54(9):2016-22. Epub 2013 Jan 29.

Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.763123DOI Listing
September 2013

Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling.

Blood 2013 Feb 20;121(9):1501-9. Epub 2012 Dec 20.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-452607DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968370PMC
February 2013

Chronic lymphocytic leukemia therapy: beyond chemoimmunotherapy.

Curr Pharm Des 2012 ;18(23):3356-62

Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi iSunyer, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161212801227014DOI Listing
December 2012

CLL therapy: the increasing importance of predictive markers.

Authors:
Emili Montserrat

Oncology (Williston Park) 2012 Nov;26(11):1064-6

University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
November 2012

Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations.

Genes Chromosomes Cancer 2012 Sep 23;51(9):881-9. Epub 2012 May 23.

Hematopathology Unit, Pathology Department, Hospital Clínic, Institut d'Investigacions Biomédiques Agustí Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.21972DOI Listing
September 2012

PTLD treatment: a step forward, a long way to go.

Authors:
Emili Montserrat

Lancet Oncol 2012 Feb 13;13(2):120-1. Epub 2011 Dec 13.

CLL and Lymphoma Programme, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70325-4DOI Listing
February 2012

Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2011 Nov 27;52(11):2064-8. Epub 2011 Jun 27.

Institute of Hematology and Oncology, Department of Hematology, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2011.59
Publisher Site
http://dx.doi.org/10.3109/10428194.2011.591008DOI Listing
November 2011

Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.

Br J Haematol 2011 Jul 1;154(1):14-22. Epub 2011 May 1.

Department of Haematology, Institute of Haematology and Oncology, Hospital Clínic, University of Barcelona, Institute d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08707.xDOI Listing
July 2011

Autografting CLL: the game is over!

Blood 2011 Jun;117(23):6057-8

University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-04-34
Publisher Site
http://dx.doi.org/10.1182/blood-2011-04-344093DOI Listing
June 2011

Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Haematologica 2011 May 17;96(5):752-61. Epub 2011 Jan 17.

Institute of Hematology and Oncology, Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.036152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084923PMC
May 2011

Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.

Br J Haematol 2011 May 6;153(3):334-40. Epub 2011 Mar 6.

Departments of Haematology Pathology Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08596.xDOI Listing
May 2011

Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance.

Blood 2010 Dec 24;116(23):4771-6. Epub 2010 Aug 24.

Institute of Hematology and Oncology, Hematology Department, Hospital Clínic University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-05-286500DOI Listing
December 2010

Chronic lymphocytic leukemia: new concepts for future therapy.

Clin Lymphoma Myeloma Leuk 2010 Oct;10(5):369-78

University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.n.070DOI Listing
October 2010

International network of cancer genome projects.

Authors:
Thomas J Hudson Warwick Anderson Axel Artez Anna D Barker Cindy Bell Rosa R Bernabé M K Bhan Fabien Calvo Iiro Eerola Daniela S Gerhard Alan Guttmacher Mark Guyer Fiona M Hemsley Jennifer L Jennings David Kerr Peter Klatt Patrik Kolar Jun Kusada David P Lane Frank Laplace Lu Youyong Gerd Nettekoven Brad Ozenberger Jane Peterson T S Rao Jacques Remacle Alan J Schafer Tatsuhiro Shibata Michael R Stratton Joseph G Vockley Koichi Watanabe Huanming Yang Matthew M F Yuen Bartha M Knoppers Martin Bobrow Anne Cambon-Thomsen Lynn G Dressler Stephanie O M Dyke Yann Joly Kazuto Kato Karen L Kennedy Pilar Nicolás Michael J Parker Emmanuelle Rial-Sebbag Carlos M Romeo-Casabona Kenna M Shaw Susan Wallace Georgia L Wiesner Nikolajs Zeps Peter Lichter Andrew V Biankin Christian Chabannon Lynda Chin Bruno Clément Enrique de Alava Françoise Degos Martin L Ferguson Peter Geary D Neil Hayes Thomas J Hudson Amber L Johns Arek Kasprzyk Hidewaki Nakagawa Robert Penny Miguel A Piris Rajiv Sarin Aldo Scarpa Tatsuhiro Shibata Marc van de Vijver P Andrew Futreal Hiroyuki Aburatani Mónica Bayés David D L Botwell Peter J Campbell Xavier Estivill Daniela S Gerhard Sean M Grimmond Ivo Gut Martin Hirst Carlos López-Otín Partha Majumder Marco Marra John D McPherson Hidewaki Nakagawa Zemin Ning Xose S Puente Yijun Ruan Tatsuhiro Shibata Michael R Stratton Hendrik G Stunnenberg Harold Swerdlow Victor E Velculescu Richard K Wilson Hong H Xue Liu Yang Paul T Spellman Gary D Bader Paul C Boutros Peter J Campbell Paul Flicek Gad Getz Roderic Guigó Guangwu Guo David Haussler Simon Heath Tim J Hubbard Tao Jiang Steven M Jones Qibin Li Nuria López-Bigas Ruibang Luo Lakshmi Muthuswamy B F Francis Ouellette John V Pearson Xose S Puente Victor Quesada Benjamin J Raphael Chris Sander Tatsuhiro Shibata Terence P Speed Lincoln D Stein Joshua M Stuart Jon W Teague Yasushi Totoki Tatsuhiko Tsunoda Alfonso Valencia David A Wheeler Honglong Wu Shancen Zhao Guangyu Zhou Lincoln D Stein Roderic Guigó Tim J Hubbard Yann Joly Steven M Jones Arek Kasprzyk Mark Lathrop Nuria López-Bigas B F Francis Ouellette Paul T Spellman Jon W Teague Gilles Thomas Alfonso Valencia Teruhiko Yoshida Karen L Kennedy Myles Axton Stephanie O M Dyke P Andrew Futreal Daniela S Gerhard Chris Gunter Mark Guyer Thomas J Hudson John D McPherson Linda J Miller Brad Ozenberger Kenna M Shaw Arek Kasprzyk Lincoln D Stein Junjun Zhang Syed A Haider Jianxin Wang Christina K Yung Anthony Cros Anthony Cross Yong Liang Saravanamuttu Gnaneshan Jonathan Guberman Jack Hsu Martin Bobrow Don R C Chalmers Karl W Hasel Yann Joly Terry S H Kaan Karen L Kennedy Bartha M Knoppers William W Lowrance Tohru Masui Pilar Nicolás Emmanuelle Rial-Sebbag Laura Lyman Rodriguez Catherine Vergely Teruhiko Yoshida Sean M Grimmond Andrew V Biankin David D L Bowtell Nicole Cloonan Anna deFazio James R Eshleman Dariush Etemadmoghadam Brooke B Gardiner Brooke A Gardiner James G Kench Aldo Scarpa Robert L Sutherland Margaret A Tempero Nicola J Waddell Peter J Wilson John D McPherson Steve Gallinger Ming-Sound Tsao Patricia A Shaw Gloria M Petersen Debabrata Mukhopadhyay Lynda Chin Ronald A DePinho Sarah Thayer Lakshmi Muthuswamy Kamran Shazand Timothy Beck Michelle Sam Lee Timms Vanessa Ballin Youyong Lu Jiafu Ji Xiuqing Zhang Feng Chen Xueda Hu Guangyu Zhou Qi Yang Geng Tian Lianhai Zhang Xiaofang Xing Xianghong Li Zhenggang Zhu Yingyan Yu Jun Yu Huanming Yang Mark Lathrop Jörg Tost Paul Brennan Ivana Holcatova David Zaridze Alvis Brazma Lars Egevard Egor Prokhortchouk Rosamonde Elizabeth Banks Mathias Uhlén Anne Cambon-Thomsen Juris Viksna Fredrik Ponten Konstantin Skryabin Michael R Stratton P Andrew Futreal Ewan Birney Ake Borg Anne-Lise Børresen-Dale Carlos Caldas John A Foekens Sancha Martin Jorge S Reis-Filho Andrea L Richardson Christos Sotiriou Hendrik G Stunnenberg Giles Thoms Marc van de Vijver Laura van't Veer Fabien Calvo Daniel Birnbaum Hélène Blanche Pascal Boucher Sandrine Boyault Christian Chabannon Ivo Gut Jocelyne D Masson-Jacquemier Mark Lathrop Iris Pauporté Xavier Pivot Anne Vincent-Salomon Eric Tabone Charles Theillet Gilles Thomas Jörg Tost Isabelle Treilleux Fabien Calvo Paulette Bioulac-Sage Bruno Clément Thomas Decaens Françoise Degos Dominique Franco Ivo Gut Marta Gut Simon Heath Mark Lathrop Didier Samuel Gilles Thomas Jessica Zucman-Rossi Peter Lichter Roland Eils Benedikt Brors Jan O Korbel Andrey Korshunov Pablo Landgraf Hans Lehrach Stefan Pfister Bernhard Radlwimmer Guido Reifenberger Michael D Taylor Christof von Kalle Partha P Majumder Rajiv Sarin T S Rao M K Bhan Aldo Scarpa Paolo Pederzoli Rita A Lawlor Massimo Delledonne Alberto Bardelli Andrew V Biankin Sean M Grimmond Thomas Gress David Klimstra Giuseppe Zamboni Tatsuhiro Shibata Yusuke Nakamura Hidewaki Nakagawa Jun Kusada Tatsuhiko Tsunoda Satoru Miyano Hiroyuki Aburatani Kazuto Kato Akihiro Fujimoto Teruhiko Yoshida Elias Campo Carlos López-Otín Xavier Estivill Roderic Guigó Silvia de Sanjosé Miguel A Piris Emili Montserrat Marcos González-Díaz Xose S Puente Pedro Jares Alfonso Valencia Heinz Himmelbauer Heinz Himmelbaue Victor Quesada Silvia Bea Michael R Stratton P Andrew Futreal Peter J Campbell Anne Vincent-Salomon Andrea L Richardson Jorge S Reis-Filho Marc van de Vijver Gilles Thomas Jocelyne D Masson-Jacquemier Samuel Aparicio Ake Borg Anne-Lise Børresen-Dale Carlos Caldas John A Foekens Hendrik G Stunnenberg Laura van't Veer Douglas F Easton Paul T Spellman Sancha Martin Anna D Barker Lynda Chin Francis S Collins Carolyn C Compton Martin L Ferguson Daniela S Gerhard Gad Getz Chris Gunter Alan Guttmacher Mark Guyer D Neil Hayes Eric S Lander Brad Ozenberger Robert Penny Jane Peterson Chris Sander Kenna M Shaw Terence P Speed Paul T Spellman Joseph G Vockley David A Wheeler Richard K Wilson Thomas J Hudson Lynda Chin Bartha M Knoppers Eric S Lander Peter Lichter Lincoln D Stein Michael R Stratton Warwick Anderson Anna D Barker Cindy Bell Martin Bobrow Wylie Burke Francis S Collins Carolyn C Compton Ronald A DePinho Douglas F Easton P Andrew Futreal Daniela S Gerhard Anthony R Green Mark Guyer Stanley R Hamilton Tim J Hubbard Olli P Kallioniemi Karen L Kennedy Timothy J Ley Edison T Liu Youyong Lu Partha Majumder Marco Marra Brad Ozenberger Jane Peterson Alan J Schafer Paul T Spellman Hendrik G Stunnenberg Brandon J Wainwright Richard K Wilson Huanming Yang

Nature 2010 Apr;464(7291):993-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature08987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902243PMC
April 2010

Advances in biology and therapy of chronic lymphocytic leukemia. Preface.

Authors:
Emili Montserrat

Best Pract Res Clin Haematol 2010 Mar;23(1):1-2

Institute of Hematology and Oncology, Department of Hematology, Hospital Clínic, C/Villarroel 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2010.03.001DOI Listing
March 2010

Genetic lesions in chronic lymphocytic leukemia: clinical implications.

Curr Opin Oncol 2009 Nov;21(6):609-14

Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Villarroel, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2009/11000/Genetic_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e328331b702DOI Listing
November 2009

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

Leuk Lymphoma 2009 Nov;50(11):1854-9

Unit of Human Anatomy, Molecular Oncology Laboratory, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903147645DOI Listing
November 2009

Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.

Blood 2009 Oct 7;114(14):2945-51. Epub 2009 Aug 7.

Human Anatomy Unit, Molecular Oncology and Embryology Laboratory, University of Barcelona Medical School, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-02-204842DOI Listing
October 2009

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience.

Blood 2009 Sep 24;114(10):2044-50. Epub 2009 Jun 24.

Department of Hematology, Institute of Hematology and Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-04-214346DOI Listing
September 2009

Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.

Blood 2009 Aug 18;114(8):1563-75. Epub 2009 Jun 18.

Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-02-207654DOI Listing
August 2009

B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity.

Leuk Lymphoma 2009 Jul;50(7):1075-82

Department of Hematology, Hospital Clinic, Institute of Hematology and Oncology, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190903013334DOI Listing
July 2009

Unfolding a CLL mystery.

Authors:
Emili Montserrat

Blood 2009 Jul;114(3):498

University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-05-219360DOI Listing
July 2009

Gene expression profiling in chronic lymphocytic leukaemia.

Best Pract Res Clin Haematol 2009 Jun;22(2):211-22

Department of Hematology and Laboratory of Experimental Hematology, Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2009.05.006DOI Listing
June 2009

p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.

Clin Cancer Res 2009 Apr 7;15(8):2767-76. Epub 2009 Apr 7.

Authors' Affiliations: Hematopathology Unit, Department of Pathology and Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2382DOI Listing
April 2009

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

J Clin Oncol 2009 Mar 17;27(9):1470-6. Epub 2009 Feb 17.

Hematopathology Section, Department of Pathology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi-Sunyer, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.0513DOI Listing
March 2009

Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.

Haematologica 2008 Dec 22;93(12):1843-51. Epub 2008 Oct 22.

Unitat d'Hematopatologia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.13186DOI Listing
December 2008

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.

Cancer Res 2008 Dec;68(24):10178-86

Department of Anatomic Pathology, Hematopathology Section, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-2221DOI Listing
December 2008

Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.

Clin Cancer Res 2008 Nov;14(21):6907-15

Hematopathology Unit, Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0388DOI Listing
November 2008

Further progress in CLL therapy.

Authors:
Emili Montserrat

Blood 2008 Aug;112(4):924-5

University of Barcelona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-05-155721DOI Listing
August 2008

New prognostic markers in chronic lymphocytic leukemia.

Blood Rev 2008 Jul 29;22(4):211-9. Epub 2008 Apr 29.

Institute of Hematology and Oncology, Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2008.03.003DOI Listing
July 2008

MicroRNA expression profiling in classic Hodgkin lymphoma.

Blood 2008 Mar 18;111(5):2825-32. Epub 2007 Dec 18.

Department of Human Anatomy and Embryology, Laboratory of Molecular Oncology, School of Medicine, Barcelona University, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-06-096784DOI Listing
March 2008

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment.

Haematologica 2008 Jan;93(1):75-82

Department of Hematology, Laboratory of Experimental Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11546DOI Listing
January 2008

Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia.

Haematologica 2008 Jan;93(1):132-6

Hematopathology Section, Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11694DOI Listing
January 2008

Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: long-term outcome of 61 patients from a single institution.

Leuk Lymphoma 2007 Oct;48(10):1968-75

Department of Hematology, Institute of Hematology and Oncology, Institut d'Investigacions Biomèdiques August Pi I Sunyer IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701573265DOI Listing
October 2007

[Autologous haematopoietic stem cell transplantation in POEMS syndrome: results in 4 cases].

Med Clin (Barc) 2007 Oct;129(15):578-81

Instituto de Hematología y Oncología, Servicio de Hematología, Unidad de TPH, Hospital Clínic, IDIBAPS, Universidad de Barcelona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13111711DOI Listing
October 2007

The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.

Best Pract Res Clin Haematol 2007 Sep;20(3):529-43

Institute of Hematology and Oncology, Department of Hematology Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Villarroel, 170-08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2007.03.002DOI Listing
September 2007

New prognostic markers in CLL.

Authors:
Emili Montserrat

Hematology Am Soc Hematol Educ Program 2006 :279-84

Department of Hematology, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2006.1.279DOI Listing
June 2007

Leukemic involvement is a common feature in mantle cell lymphoma.

Cancer 2007 Jun;109(12):2473-80

Department of Hematology, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22715DOI Listing
June 2007

Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia.

J Clin Oncol 2007 Apr 12;25(12):1576-80. Epub 2007 Mar 12.

Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2006.08.4194
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.08.4194DOI Listing
April 2007

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

Blood 2006 Nov 6;108(9):2957-64. Epub 2006 Jul 6.

Hematopathology Section, Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-018218DOI Listing
November 2006

Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.

J Clin Oncol 2006 Oct 25;24(30):4855-61. Epub 2006 Sep 25.

Department of Hematology, Institute of Hematology and Oncology, IDIBAPS, Postgraduate School of Hematology Farreras Valentí, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/24/30/4855.full.pdf
Web Search
http://www.jco.org/cgi/doi/10.1200/JCO.2006.06.4238
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.06.4238DOI Listing
October 2006

Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.

Haematologica 2006 Oct;91(10):1372-6

Department of Hematology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Faculty of Medicine, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
October 2006

Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia.

Br J Haematol 2006 Jul 1;134(2):184-6. Epub 2006 Jun 1.

Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06142.xDOI Listing
July 2006

Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.

Cytometry B Clin Cytom 2006 Jul;70(4):214-7

Department of Hematology and Laboratory of Experimental Hematology, Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.20131DOI Listing
July 2006

Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults.

Transpl Immunol 2006 Jun 31;16(1):52-9. Epub 2006 Mar 31.

Department of Hematology, Institute of Hematology and Oncology, Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Hospital Clínic, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2006.02.006DOI Listing
June 2006

Bortezomib: an effective agent in extramedullary disease in multiple myeloma.

Eur J Haematol 2006 May 9;76(5):405-8. Epub 2006 Mar 9.

Institute of Hematology and Oncology, Hematology Department, IDIBAPS Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0902-4441.2005.t01-1-EJH2462.xDOI Listing
May 2006